Letko Brosseau & Associates Inc. maintained its stake in Aetna Inc. (NYSE:AET) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,700 shares of the company’s stock at the close of the second quarter. Letko Brosseau & Associates Inc.’s holdings in Aetna were worth $410,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently modified their holdings of the company. NBT Bank N A NY purchased a new position in Aetna in the 2nd quarter worth about $215,000. State of Tennessee Treasury Department increased its stake in Aetna by 26.3% in the 2nd quarter. State of Tennessee Treasury Department now owns 557,814 shares of the company’s stock worth $84,692,000 after purchasing an additional 116,280 shares in the last quarter. Pictet & Cie Europe SA purchased a new position in Aetna in the 2nd quarter worth about $2,269,000. Cambridge Investment Research Advisors Inc. increased its stake in Aetna by 4.5% in the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 36,731 shares of the company’s stock worth $5,577,000 after purchasing an additional 1,590 shares in the last quarter. Finally, Keybank National Association OH increased its stake in Aetna by 1.2% in the 2nd quarter. Keybank National Association OH now owns 421,535 shares of the company’s stock worth $64,001,000 after purchasing an additional 5,199 shares in the last quarter. 89.58% of the stock is currently owned by hedge funds and other institutional investors.
COPYRIGHT VIOLATION WARNING: “Aetna Inc. (AET) Stake Held by Letko Brosseau & Associates Inc.” was first posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this news story on another website, it was illegally copied and reposted in violation of international copyright & trademark laws. The original version of this news story can be read at https://www.chaffeybreeze.com/2017/09/15/aetna-inc-aet-stake-held-by-letko-brosseau-associates-inc.html.
A number of brokerages recently weighed in on AET. Argus reissued a “buy” rating and issued a $165.00 price target (up previously from $145.00) on shares of Aetna in a research note on Tuesday, May 30th. ValuEngine raised Aetna from a “hold” rating to a “buy” rating in a research note on Friday, June 2nd. BidaskClub cut Aetna from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 19th. Deutsche Bank AG lifted their price target on Aetna from $144.00 to $157.00 and gave the stock a “hold” rating in a research note on Thursday, July 13th. Finally, Cowen and Company set a $170.00 price target on Aetna and gave the stock a “buy” rating in a research note on Saturday, May 27th. Seven analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $159.04.
Shares of Aetna Inc. (NYSE AET) traded down 0.11% during midday trading on Friday, hitting $162.60. The stock had a trading volume of 649,175 shares. The firm’s 50-day moving average is $157.04 and its 200 day moving average is $144.83. The company has a market capitalization of $54.00 billion, a PE ratio of 36.09 and a beta of 0.53. Aetna Inc. has a one year low of $104.59 and a one year high of $164.52.
Aetna (NYSE:AET) last announced its quarterly earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.34 by $1.08. The company had revenue of $15.52 billion during the quarter, compared to the consensus estimate of $15.34 billion. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The company’s revenue for the quarter was down 2.7% compared to the same quarter last year. During the same period in the prior year, the company earned $2.21 earnings per share. Equities analysts expect that Aetna Inc. will post $9.55 earnings per share for the current fiscal year.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.